Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Freedom Acquisition I Corp. (FACT-UN)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
9.90+0.01 (+0.05%)
At close: 02:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.89
Open9.90
Bid9.77 x 1200
Ask15.85 x 1000
Day's Range9.90 - 9.90
52 Week Range9.77 - 10.02
Volume1,800
Avg. Volume22,313
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuters

    Human Longevity plans to go public in $1 bln blank-check deal

    Genome sequencing company Human Longevity Inc plans to go public through a merger with Freedom Acquisition I Corp that values the combined company at about $1 billion, the two companies said on Monday. Freedom Acquisition I Corp is a special purpose acquisition company led by former Credit Suisse chief executive Tidjane Thiam, and was listed early last year. A blank-check firm, or a special purpose acquisition company (SPAC), is a listed shell entity that uses the money raised in its IPO to merge with a private company, taking it public in the process.

  • Business Wire

    Human Longevity, Inc., and Freedom Acquisition 1 announce their intention to combine

    SAN DIEGO & LONDON, June 20, 2022--Human Longevity, Inc. ("HLI"), built by the pioneers of the human genome sequencing effort, and Freedom Acquisition I Corporation ("Freedom") (NYSE: FACT), a publicly traded special purpose acquisition company, announced today that they have signed a non-binding letter of intent (the "Letter of Intent") for a proposed business combination that would result in HLI becoming a publicly listed company. Upon the closing of the transaction, the combined company would

  • Bloomberg

    Pimco Stops Sponsoring Ex-Credit Suisse Boss’s SPAC

    (Bloomberg) -- Fund management giant Pimco has ended its role as a sponsor of former Credit Suisse Group AG Chief Executive Officer Tidjane Thiam’s fintech SPAC.Most Read from BloombergSwitzerland Imports Russian Gold for First Time Since WarThe World’s Bubbliest Housing Markets Are Flashing Warning SignsLiz Cheney Is Paying the Price in Her Home State for Crossing TrumpStocks Surge After $2 Trillion Wipeout; Bonds Fall: Markets WrapStocks Drop, Bonds Surge With All Eyes on Powell: Markets WrapP

Advertisement
Advertisement